Systematic Review: Rituximab for thyroid‐associated ophthalmopathy. 20 Jun, 2022 | 01:16h | UTC Rituximab for thyroid‐associated ophthalmopathy – Cochrane Library Summary: What are the benefits and risks of rituximab (a medicine that reduces inflammation) for the treatment of thyroid-associated ophthalmopathy (a disease affecting the tissues surrounding the eyes) – Cochrane Library